PlainRecalls
FDA Drug Low Class III Completed

Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16

Reported: February 12, 2025 Initiated: January 7, 2025 #D-0222-2025

Product Description

Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16

Reason for Recall

Superpotent; sodium benzoate preservative

Details

Units Affected
4080 Bottles
Distribution
OH
Location
Greenville, SC

Frequently Asked Questions

What product was recalled?
Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16. Recalled by PAI Holdings, LLC. dba Pharmaceutical Associates Inc. Units affected: 4080 Bottles.
Why was this product recalled?
Superpotent; sodium benzoate preservative
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2025. Severity: Low. Recall number: D-0222-2025.